Monday, November 13, 2017

Novartis launches heart drug counter-offensive

  1. Novartis launches heart drug counter-offensive  Reuters
  2. AHA: CANTOS Substudy Supports Major Role Of Inflammation  MedPage Today
  3. Secondary CANTOS Analysis IDs Canakinumab Responders  MedscapeFull coverage

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.